Gene: MKRN3
Official Full Name: makorin ring finger protein 3provided by HGNC
Gene Summary: The protein encoded by this gene contains a RING (C3HC4) zinc finger motif and several C3H zinc finger motifs. This gene is intronless and imprinted, with expression only from the paternal allele. Disruption of the imprinting at this locus may contribute to Prader-Willi syndrome. An antisense RNA of unknown function has been found overlapping this gene. [provided by RefSeq, Jul 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO34613 | MKRN3 Knockout cell line (HeLa) | Human | MKRN3 | 1:3~1:6 | Negative | Online Inquiry |
KO34614 | MKRN3 Knockout cell line (HCT 116) | Human | MKRN3 | 1:2~1:4 | Negative | Online Inquiry |
KO34615 | MKRN3 Knockout cell line (A549) | Human | MKRN3 | 1:3~1:4 | Negative | Online Inquiry |
MKRN3 Gene Knockout Cell Lines are specialized cellular models that facilitate the study of the MKRN3 gene, which plays a critical role in the regulation of puberty onset and other hormonal processes. This product consists of genetically modified cell lines where the MKRN3 gene has been inactivated or "knocked out," allowing researchers to investigate the functional implications of MKRN3 deficiency in a controlled environment.
The primary function of MKRN3 is to serve as a negative regulator of the onset of puberty, primarily in the hypothalamus. By utilizing these knockout cell lines, scientists can explore the downstream effects of MKRN3 loss on neuroendocrine signaling pathways, hormonal regulation, and the overall temporal progression of sexual maturation. The mechanism of action involves an interplay between MKRN3 and key genetic regulators, such as kisspeptin and gonadotropin-releasing hormone, thereby impacting the reproductive axis in mammals.
The scientific importance of MKRN3 Gene Knockout Cell Lines is underscored by their utility in both research and clinical settings. Researchers can employ these cell lines to screen for potential therapeutic targets in disorders related to precocious puberty or delayed sexual maturation, while clinicians may find value in understanding the genetic underpinnings of such conditions to inform treatment strategies.
What sets our MKRN3 Gene Knockout Cell Lines apart from competitors is the precision of the gene editing technique utilized, ensuring a complete and reliable knockout of the MKRN3 gene. Additionally, our cell lines are rigorously validated for consistent performance across experiments, which is essential for reproducibility in research settings.
The value of employing MKRN3 Gene Knockout Cell Lines lies in their ability to provide researchers and clinicians with a reliable platform to study gene function, model diseases, and develop novel therapeutic approaches with greater precision.
At our company, we pride ourselves on our expertise in genetic engineering and cell line development, delivering high-quality biological products that support advancements in biomedical research and therapeutic innovations.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.